InDex Pharmaceuticals will participate in the European Crohn’s and Colitis Organisation (ECCO) Congress
January 23, 2017 – InDex Pharmaceuticals Holding AB (publ) today announced that the company will have two posters at the 12th congress of the European Crohn’s and Colitis Organisation (ECCO). The ECCO congress is the largest congress in the world with a specific focus on inflammatory bowel disease (IBD). The congress is held in Barcelona, Spain on February 15-18, 2017.“We are pleased to again having been selected to present data at the largest IBD congress in the world and that our results continue to meet considerable interest from the medical expertise", says Peter Zerhouni, CEO of InDex